Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 207-216

  Williams, Dominic P ^a   Pirmohamed, Munir ^a   Naisbitt, Dean J ^a   Uetrecht, Jack P ^b   Park, Brian K ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b New Medical Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

AGRANULOCYTOSIS; APOPTOSIS; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUTROPHIL; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0033938971     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.207     Document Type: Article

References (48)

1. Atkin K, Kendall F, Gould D, Freeman H, Lieberman J and O'Sullivan D (1996) The incidence of neutropenia and agranulocytosis in patients treated with clozapine in the UK and Ireland. Br J Psychiatry 169:483-488.
2. Babior BM (1984) The respiratory burst of phagocytes. J Clin Invest 73:599-601.
3. Balazovich KJ, Suchard SJ, Remick DG and Boxer LA (1996) Tumor-necrosis-factor-alpha and fmlp receptors are functionally linked during fmlp-stimulated activation of adherent human neutrophils. Blood 88:690-696.
4. Baldessarini RJ and Frankenburg FR (1991) Clozapine. A novel antipsychotic agent. N Engl J Med 324:746-754.
5. Buttke TM and Sandatrom PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15:7-10.
6. Chao JR, Wang JM, Lee SF, Peng HW, Lin YH, Chou CH, Huang HM, Chou CK, Kuo ML, Yen JJ and Yang-Yen HF (1998) MCl-1 is an immediate early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response. Mol Cell Biol 18:4883-4898.
7. Chengappa KN, Gopalani A, Haught MK, McChesney K, Baker RW and Schooler NR (1996) The treatment of clozapine-associated agranulocytosis with granulocyte colony-stimulating factor (G-CSF). Psychopharmacol Bull 32:111-121.
8. Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA and Yunis EJ (1995) The major histocompatibility complex region marked by hsp70-1 and hsp70-2 variants is associated with clozapine-induced agranulocytosis in 2 different ethnic-groups. Blood 86:3835-3840.
9. Cotgreave IA and Moldeus P (1986) Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems. J Biochem Biophys Methods 13:231-249.
10. Cox G (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils -separation of survival and activation outcomes. J Immunol 154:4719-4725.
11. Eastmond DA, Smith MT, Ruzo LO and Rosa D (1986) Metabolic-activation of phenol by human myeloperoxidase and horseradish-peroxidase. Mol Pharmacol 30:674-679.
12. Fischer V, Haar JA, Greiner L, Lloyd RV and Mason RP (1991) Possible role of free radical formation in clozapine (Clozaril)-induced agranulocytosis. Mol Pharmacol 40:846-853.
13. Gardner I, Leeder JS, Chin T, Zahid N and Uetrecht JP (1998a) A comparison of the covalent binding of clozapine and olanzepine to human neutrophils in vitro and in vivo. Mol Pharmacol 53:999-1008.
14. Gardner I, Zahid N, MaCrimmon D and Uetrecht JP (1998b) A comparison of the oxidation of clozapine and olanzepine to reactive metabolites and toxicity of these metabolites to human leukocytes. Mol Pharmacol 53:991-998.
15. Gerson SL (1993) Clozapine - deciphering the risks. N Engl J Med 329:204-205.
16. Gerson SL (1994) G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry 55:139-142.
17. Guest I, Sokoluk B, MacCrimmon J and Uetrecht J (1998) Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis. Toxicology 131:53-65.
18. Hockenbery DM, Zutter M, Hickey W, Nahm M and Korsmeyer SJ (1991) Bcl2 protein is topographically restricted in tissues characterized by apoptotic cell-death. Proc Natl Acad Sci USA 88:6961-6965.
19. Jann MW, Grimsley SR, Gray EC and Chang WH (1993) Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 24:161-176.
20. Jaunkalns R, Shear NH, Sokoluk B, Gardner D, Claas F and Uetrecht JP (1992) Antimyeloperoxidase antibodies and adverse reactions to clozapine. Lancet 339: 1611-1612.
21. Korsmeyer SJ, Yin XM, Oltvai ZN, Veisnovack DJ and Linette GP (1995) Reactive oxygen species and the regulation of cell-death by the bcl-2 gene family. Biochim Biophys Acta 1271:63-66.
22. Leist M, Single B, Castoldi AF, Kuhnle S and Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J Exp Med 186:1484-1486.
23. Liu ZC and Uetrecht JP (1995) Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to cells. J Pharmacol Exp Ther 275:1476-1483.
24. Maggs JL, Williams D, Pirmohamed M and Park BK (1995) The metabolic formation of reactive intermediates from clozapine: A drug associated with agranulocytosis in man. J Pharmacol Exp Ther 275:1463-1475.
25. McGuiness SM, Johansson R, Lundstrom J and Ross D (1999) Induction of apoptosis by remoxipride metabolites in HL-60 and CD34+/CD19-human bone marrow progenitor cells: Potential relevance to remoxipride-induced aplastic anaemia. Chem Biol Interact 121:253-265.
26. Moeschlin S and Wagner K (1952) Agranulocytosis due to the occurrence of leucocyte-agglutinins. Acta Haematol 8:29-41.
27. Moulding DA, Quayle JA, Hart A and Edwards SW (1998) Mcl-1 expression in human neutrophils: Regulation by cytokines and correlation with cell survival. Blood 92:2495-2502.
28. Nicoletti I, Migliorati G, Paggliacci MC, Grigani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279.
29. Nishio E and Watanabe Y (1997) Nitric oxide donor-induced apoptosis in smooth muscle cells is modulated by protein kinase C and protein kinase A. Eur J Pharmacol 339:245-251.
30. Park JR, Bernstein ID and Hockenbery DM (1995) Primitive human hematopoietic precursors express bcl-X but not bcl-2. Blood 86:868-876.
31. Payne CM, Glasser L, Tischler ME, Wyckoff D, Cromey D, Fiederlein R and Bohnert O (1994) Programmed cell death of the normal human neutrophil - an in-vitro model of senescence. Microsc Res Tech 28:327-344.
32. Philpott NJ, Marsh JCW and Gordon-Smith E (1993) Aplastic anaemia and remoxipride. Lancet 342:1244-1245.
33. Pirmohamed M and Park BK (1997) Mechanism of action of clozapine-induced agranulocytosis: Current status of research and implications for drug development. Cent Nerv Syst Drugs 7:139-158.
34. Pirmohamed M, Williams D, Madden S, Templeton E and Park Bk (1995) Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther 272:984-990.
35. Ross D, Siegel D, Schattenberg DG, Sun XMM and Moran JL (1996) Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: Identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ Health Perspect 104:1177-1182.
36. Sperner-Unterweger B, Gaggl S, Fleischhacker WW, Barnas C, Herold M and Geissler D (1993) Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry 34:536-543.
37. Takano M, Arai T, Mokuno Y, Nishimura Y and Yoshikai Y (1998) Dibutyryl cyclic adenosine monophosphate protects mice against TNF-alpha-induced hepatocyte apoptosis accompanied by increasing heat shock protein 70 expression. Cell Stress Chaperones 3:109-117.
38. Tschen AC, Rieder MJ, Oyewumi LK and Freeman DJ (1999) The cytotoxicity of clozapine metabolites: Implications for predicting clozapine-induced agranulocytosis. Clin Pharm Ther 65:526-532.
39. Turbay D, Lieberman J, Alper CA, Delgado JC, Corzo D, Yunis JJ and Yunis EJ (1997) Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. Blood 89:4167-4174.
40. Uetrecht JP (1992a) The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. Drug Metab Rev 24:299-366.
41. Uetrecht JP (1992b) Metabolism of clozapine by neutrophils. Possible implications for clozapine-induced agranulocytosis. Drug Saf 7:51-56.
42. Uetrecht J, Zahid N, Tehim A, Fu JM and Rakhit S (1997) Structural features associated with reactive metabolite formation in clozapine analogues. Chem Biol Interact 104:117-129.
43. Vennes I, Haanen C, Steffens-Nakken H and Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184:39-51.
44. Watson RWG, Holstein OD, Nachens AB, Dackiw APB and Marshall JC (1996) Thiol-mediated redox regulation of neutrophil apoptosis. Surgery 120:150-158.
45. Whyte MKB, Savill J, Meagher LC, Lee A and Haslett C (1997) Coupling of neutrophil apoptosis to recognition by macrophages: Coordinated acceleration by protein synthesis inhibitors. J Leukoc Biol 62:195-202.
46. Wiemels J, Wiencke JK, Varykoni A and Smith MT (1999) Modulation of the toxicity and macromolecular binding of benzene metabolites by NAD(P)H:quinone oxidoreductase in transfected HL-60 cells. Chem Res Toxicol 12:467-475.
47. Williams DP, Pirmohamed M, Naiabitt DJ, Maggs JL and Park BK (1997) Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: Possible role in agranulocytosis. J Pharmacol Exp Ther 283:1375-1382.
48. Yousefi S, Green DR, Blaser K and Simon HU (1994) Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci USA 91:10868-10872.